📰 Study Sites News
Study Sites News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Study Sites. Real-time updates on events, politics, business and more.
July 4, 2024
The urgent manhunt, with residents scared and frustrated, and school is canceled for another day. Here are tonights headlines. The stunning video shows the killer scaling a wall, then pushing through razor wire and running across the roof. Plus, one of the major obstacles facing search teams. The Undergrowth Fear of it is so thick, searchers can only go a few feet before losing sight of each other. Federal prosecutors say they plan to bring an indictment against hunter biden by late september. T...
January 28, 2024
Pregnant women exposed to specific classes of flame-retardant chemicals may face an increased risk of preterm birth, especially for baby girls, or higher birth weights, according to a Rutgers Health researcher.
January 26, 2024
DPHP, DBUP/DIBP, and bis(1,3-dichloro-2-propyl) phosphate shorten pregnancies and increase preterm birth risks in females.
January 26, 2024
Rutgers Health participated in a federal study that found certain organophosphate esters were linked to increased risk of early birth, especially in girls
January 26, 2024
Rutgers Health participated in a federal study that found certain organophosphate esters were linked to increased risk of early birth, especially in girls
January 25, 2024
An NIH Environmental influences on Child Health Outcomes (ECHO) Cohort study finds that certain organophosphate esters (OPEs) were linked to increased odds of p
January 25, 2024
An NIH Environmental influences on Child Health Outcomes (ECHO) Cohort study finds that certain organophosphate esters (OPEs) were linked to increased odds of p
May 31, 2023
In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®
May 31, 2023
TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development
April 26, 2023
TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...